Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20221002056076N1Phase 3Completed
Phase 3, randomised trial of clotrimazole in vulvovaginal candidiasis (VVC) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Clinical and mycological cure of vaginal candidiasis. Started Aug 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20221002056076N1.